Investors and analysts have given it some thought and mostly think it's a sensible acquisition. Source: BioSpace

These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace

Fresh off its $7B acquisition, Celgene is planning to open a biopharma incubator on its corporate campus in New Jersey. Source: BioSpace

This Latest move is a wide-ranging effort to boost competitiveness. Source: BioSpace

The 2016 U.S. presidential election was marked by aggressive and often shrill attacks on the biopharma industry over drug pricing. Source: BioSpace

Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace

Thirty years ago, neurologist Leonard S. Schliefer, MD, PhD, founded Regeneron, a life sciences company dedicated to discovering, developing and bringing new medications to the patients who need them. Source:…

After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the…

Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly. Source: BioSpace

The company could be hoping the new hire will provide a consultative resource for all health-care regulatory issues. Source: BioSpace